Management of older adults with type 2 diabetes and chronic kidney disease is complex. These individuals often have multiple comorbidities, take several medications, and are at increased risk of ...

Finerenone (Kerendia) is thought to work by inhibiting inflammation that can cause kidney damage, according to Drugs.com. The ...

A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...

Discover why urinating more than 8 times daily could signal 2 life-threatening conditions. Learn the warning signs your body ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle ...

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of ...

Diabetes drug dapagliflozin could also be beneficial for patients with progressive liver disease, a clinical trial has shown.

Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

A new international study has found that over 15 million people across the US, UK, Germany, and France are unknowingly living ...